Misoprostol: First-line therapy for incomplete miscarriage in the developing world

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 11, 2007, Pages 1337-1339

  Gemzell Danielsson, K ^a,d   Fiala, C ^b   Weeks, A ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Gynmed Clinic   (Austria)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MISOPROSTOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; CHLAMYDIASIS; COMPARATIVE STUDY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG PACKAGING; EMERGENCY TREATMENT; FOLLOW UP; GONORRHEA; HEALTH CARE FACILITY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABOR INDUCTION; MATERNAL MORBIDITY; MATERNAL MORTALITY; NOTE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TABLET; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ADMINISTRATION, ORAL; DEVELOPING COUNTRIES; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY;

EID: 35348979651     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01491.x     Document Type: Note

References (9)

1. Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W, et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG 2007 114 : 1363 7.
2. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, et al. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomized trial in Burkina Faso, West Africa. BJOG 2007 114 : 1368 75.
3. Weeks AD, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J, Mirembe FM. A randomized trial of misoprostol versus manual vacuum aspiration for incomplete abortion. Obstet Gynecol 2005 106 : 540 7.
4. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ 2006 332 : 1235 8.
5. Cheung T, Leung P, Cheung LP, Haines C, Chang AM. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion. Acta Obstet Gynecol Scand 1997 76 : 248 51.
6. Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J NICHD Management of Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. Int J Gynaecol Obstet 2004 86 : 22 6.
7. Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol 2003 109 : 190 5.
8. Weeks AD, Fiala C, Safar P. Misoprostol and the debate over off-label drug use. BJOG 2005 112 : 269 72.
9. FLASOG (Federacion Latinoamericana de Sociedades de Obstetricia y Ginecologia). Uso de Misoprostol en Obstetricia y Ginecologia. Santa Cruz de la Sierra, Bolivia 2005.